2019 All Hands Meeting
Life Sciences Track Agenda

Update     Nuts+Bolts     Deep Dive
Scenarios & Stories     Country/Region     Sector

Tuesday, Nov 19
New Technologies: Challenges and Opportunities for FDA and Industry

Scott Cunningham & Amy Toro/Michael Listgarten
Covington & Burling LLP/(Independent)

This presentation looks at how to navigate current FDA rules and policies when developing products involving AI, telemedicine, digital healthcare, etc.

Tuesday, Nov 19
Negotiating for the Next Stage: Preserving Leverage in Life Science Company Deals

Tom Duley/Christine Ring
Sidley Austin LLP/Nurix Therapeutics, Inc.

Deals between large and small life science companies often happen in stages. Although negotiating them doesn't require clairvoyance, it always pays to frame the current stage with the next one in mind, to enhance your company's negotiating position in the following round. Drawing from a variety of life science company deals, this presentation will examine various strategies for preserving your company's future leverage.

Tuesday, Nov 19
HIPAA Update

Brandon Ge & Kristin Madigan
Crowell & Moring LLP

Tech companies often become subject to HIPAA's health information privacy and security regulations as "business associates" by handling and creating individually identifiable health information on behalf of "covered entities" - health plans, health care clearinghouses, and most health care providers. This presentation discusses some important factors to consider in determining whether your company is subject to HIPAA. This discussion will focus on what in-house counsel need to know about the consequent HIPAA compliance obligations and recent HIPAA enforcement trends and regulatory guidance, including the interplay between HIPAA and recent state consumer privacy law, such as the California Consumer Privacy Act.

Tuesday, Nov 19
Life Science IP Update

Megan Baca
Ropes & Gray

A discussion of the most important IP developments for life science companies, with an in-house perspective.

Please Note: Program details are subject to change without notice

2019 Participating Law Firms & Companies